secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0000950170-24-005068
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix appoints Julie Andrews as CFO with inducement stock awards and severance agreement
--------------------------------------------------------------------------------

- Julie Andrews started as CFO on Jan 15, 2024; previously CFO at Smart Wires and SVP Finance at Wright Medical.
- Received inducement grants: performance-based RSUs for 65,934 shares (at target), time-based RSUs for 32,967 shares, and options for 76,878 shares.
- Severance equal to 1.0x base salary + target bonus (1.5x on change in control) plus COBRA reimbursement for up to 12 months.
- Options vest when service conditions met and stock price averages 150% of grant date price over one month.
- Interim CFO Geoffrey Gillespie thanked; company expects Andrews to help drive growth and shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/0000950170-24-005068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/ofix-20240115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-005068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer